Thanks for your quick reply. I ran a test run with both the references in the same command.
Unconfigured Ad
Collapse
X
-
Hi Brian,
I'm trying to use bbsplit to separate rnaseq reads from two mixed fungal samples. I'm using the individual transcriptomes as references. I was getting some unexpected results. It seemed that more reads were unambiguously mapping to the reference that is listed first, so I swapped the order of the references and the results changed dramatically. I have ambiguous2=toss, but it seems like it's still using the first best site. Below are my commands and refstats output. Is there anything I'm doing wrong?
Thanks,
Brian
Code:bbsplit.sh ref=53.fasta,17.fasta \ in=53_30_r1_S7_R1_001.fastq.gz in2=53_30_r1_S7_R2_001.fastq.gz \ out_17=map17_53_30_r1_S7_R#_001.fastq.gz \ out_53=map53_53_30_r1_S7_R#_001.fastq.gz \ refstats=53_30_r1_S7.stats ambiguous2=toss #name %unambiguousReads unambiguousMB %ambiguousReads ambiguousMB unambiguousReads ambiguousReads 53 41.51013 1625.01508 57.30665 2219.25878 11241396 15519266 17 1.13394 44.03152 57.30665 2219.25878 307084 15519266 bbsplit.sh ref=17.fasta,53.fasta \ in=53_30_r1_S7_R1_001.fastq.gz in2=53_30_r1_S7_R2_001.fastq.gz \ out_17=map17_53_30_r1_S7_R#_001.fastq.gz \ out_53=map53_53_30_r1_S7_R#_001.fastq.gz \ refstats=53_30_r1_S7.stats2 ambiguous2=toss #name %unambiguousReads unambiguousMB %ambiguousReads ambiguousMB unambiguousReads ambiguousReads 53 21.37940 838.36051 67.54242 2623.22348 5789774 18291224 17 11.02890 426.72088 67.54242 2623.22348 2986746 18291224Last edited by GenoMax; 08-20-2018, 08:03 AM.
Comment
-
-
Contamination from human genome?
Hi,
I am working on non-model fish RNA-seq data, I am considering remove human contamination from reads, is this feasible since there is number of orthologs between human and fish?
Is there any recommendation regarding choice of "-minratio" for this case? It seems that 0.56 maybe too low? (I don't have reference genome for this non-model fish, by the way)
P.s: I think there should be different usage strategy of sensitivity or specificity for the case of binning (having 2 reference, i.e host vs contaminant, both have comparative alignment score to judge) AND for the case of decontaminating (only have the reference of contaminant, judgement only based on alignment to contaminant reference).
Thank you very much for your suggestion !
Comment
-
-
Question about BBsplit ambig2=toss and bam files
Hello!
I am using BBsplit to separate reads from a paired-end three-species bacterial RNASeq project. I set the flag ambig2=toss but then see this sentence in the print out for the code:
"Retaining first best site only for ambiguous mappings."
To me, that looks like default ambiguous=best. Is that what I should be seeing? How do I know if the ambiguous reads are being tossed?
Additionally, I am mapping directly into a bam file. From earlier posts, looks like BBsplit bam files are incompatible with IGV but would they be okay with a feature counter like HTseq or edgeR?
Thanks very much,
Amanda
Comment
-
-
@Amanda: I will need to dig through some past correspondence with Brian but I think he had recommended splitting first and then mapping to avoid the problem of having all references present in the BAM file. Which indeed causes issues with visualization programs.
If you look at the in-line help for "ambiguous2" you can see what it is doing:
Code:ambiguous2=<best> Set behavior only for reads that map ambiguously to multiple different references. Normal 'ambiguous=' controls behavior on all ambiguous reads; Ambiguous2 excludes reads that map ambiguously within a single reference.
Comment
-
-
Hi there,
I am trying to run BBSplit on a huge chr-level assembled reference genome (~24Gb) and its non-chr-level-assembled contigs (ca. 1Gb) with the following command on remote server (I specify the maximum memory use in the server as 64G).
bbsplit.sh -Xmx40g ambiguous=toss ambiguous2=toss in1=HKs_fq/HK002_L1_1_trimmed.fastq.gz in2=HKs_fq/HK002_L1_2_trimmed.fastq.gz ref=P.tabuliformis_V1.0_contig.fa,P.tabuliformis_V1.0_chr.fa basename=out_%_#.fq.gz
But the merging reference step produces much smaller (8Gb) fasta, and the mapping step also produce warning/error as follows:
Exception in thread "main" java.lang.AssertionError: Resizing to an non-longer array (2147483627); probable array size overflow.
at structures.ByteBuilder.expand(ByteBuilder.java:606)
at structures.ByteBuilder.append(ByteBuilder.java:379)
at dna.FastaToChromArrays2.nextScaffold(FastaToChromArrays2.java:539)
at dna.FastaToChromArrays2.makeNextChrom(FastaToChromArrays2.java:460)
at dna.FastaToChromArrays2.makeChroms(FastaToChromArrays2.java:345)
at dna.FastaToChromArrays2.main2(FastaToChromArrays2.java:153)
at align2.RefToIndex.makeIndex(RefToIndex.java:147)
at align2.BBMap.setup(BBMap.java:280)
at align2.AbstractMapper.<init>(AbstractMapper.java:58)
at align2.BBMap.<init>(BBMap.java:42)
at align2.BBMap.main(BBMap.java:30)
at align2.BBSplitter.main(BBSplitter.java:48)
---------------------------------
Is there anyway for me to handle this large genome and proceed adequate merging and mapping?
Comment
-
Latest Articles
Collapse
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
-
by SEQadmin2
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...-
Channel: Articles
07-08-2026, 05:17 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 07-24-2026, 12:17 PM
|
0 responses
29 views
0 reactions
|
Last Post
by SEQadmin2
07-24-2026, 12:17 PM
|
||
|
Started by SEQadmin2, 07-23-2026, 11:41 AM
|
0 responses
21 views
0 reactions
|
Last Post
by SEQadmin2
07-23-2026, 11:41 AM
|
||
|
Started by SEQadmin2, 07-20-2026, 11:10 AM
|
0 responses
211 views
0 reactions
|
Last Post
by SEQadmin2
07-20-2026, 11:10 AM
|
||
|
Started by SEQadmin2, 07-13-2026, 10:26 AM
|
0 responses
78 views
0 reactions
|
Last Post
by SEQadmin2
07-13-2026, 10:26 AM
|
Comment